Sale!

GABRG2 Gene Generalized Epilepsy with Febrile Seizures Plus Type 3 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GABRG2 Gene Generalized Epilepsy with Febrile Seizures Plus Type 3 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the GABRG2 gene. This gene plays a crucial role in the functioning of GABA receptors, which are integral for inhibiting signals in the brain. Mutations in the GABRG2 gene are associated with Generalized Epilepsy with Febrile Seizures Plus (GEFS+), a condition characterized by febrile seizures that often extend beyond the typical age range and may evolve into other types of seizures or epilepsy.

The test is particularly important for individuals with a family history of GEFS+ or related seizure disorders, as it can provide vital information for accurate diagnosis, management, and treatment planning. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the detailed insights it offers into the genetic underpinnings of epilepsy and related seizure disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test

Welcome to DNA Labs UAE, where we offer the GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test. This test helps in diagnosing and understanding the rare genetic disorder called Generalized epilepsy with febrile seizures plus type 3 (GEFS+3).

Test Components and Price

The GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test is priced at AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS (Next-generation sequencing) technology, which allows for the analysis of multiple genes simultaneously.

Test Type

The GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test falls under the category of Neurological Disorders.

Doctor and Test Department

This test is conducted by a Neurologist in our Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 NGS Genetic DNA Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with GEFS+3.

Test Details

The GABRG2 gene is associated with the rare genetic disorder called Generalized epilepsy with febrile seizures plus type 3 (GEFS+3). This disorder is characterized by recurrent febrile seizures in childhood, followed by a range of seizure types that can continue into adulthood. NGS technology allows for the sequencing of the GABRG2 gene to identify any mutations or variations that may be contributing to the disorder. Genetic testing for GEFS+3 can confirm a diagnosis, provide information about the risk of passing the disorder to future generations, guide treatment decisions, and identify at-risk family members who may benefit from genetic counseling.

Test Name GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GABRG2 Gene Generalized epilepsy with febrile seizures plus type 3
Test Details

The GABRG2 gene is associated with a rare genetic disorder called Generalized epilepsy with febrile seizures plus type 3 (GEFS+3). This disorder is characterized by recurrent febrile seizures in childhood, followed by a range of seizure types that can continue into adulthood.

NGS (Next-generation sequencing) is a genetic testing method that allows for the analysis of multiple genes simultaneously, making it a powerful tool for identifying genetic mutations associated with various disorders. In the case of GEFS+3, NGS can be used to sequence the GABRG2 gene and identify any mutations or variations that may be contributing to the disorder.

Genetic testing for GEFS+3 can help to confirm a diagnosis, provide information about the risk of passing the disorder on to future generations, and guide treatment decisions. It can also help to identify family members who may be at risk for the disorder and provide them with appropriate genetic counseling.